GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Changmao Biochemical Engineering Co Ltd (HKSE:00954) » Definitions » Return-on-Tangible-Equity

Changmao Biochemical Engineering Co (HKSE:00954) Return-on-Tangible-Equity : -17.48% (As of Dec. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Changmao Biochemical Engineering Co Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Changmao Biochemical Engineering Co's annualized net income for the quarter that ended in Dec. 2024 was HK$-105.6 Mil. Changmao Biochemical Engineering Co's average shareholder tangible equity for the quarter that ended in Dec. 2024 was HK$604.0 Mil. Therefore, Changmao Biochemical Engineering Co's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2024 was -17.48%.

The historical rank and industry rank for Changmao Biochemical Engineering Co's Return-on-Tangible-Equity or its related term are showing as below:

HKSE:00954' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -13.67   Med: 7.19   Max: 12.12
Current: -12.03

During the past 13 years, Changmao Biochemical Engineering Co's highest Return-on-Tangible-Equity was 12.12%. The lowest was -13.67%. And the median was 7.19%.

HKSE:00954's Return-on-Tangible-Equity is ranked worse than
87.46% of 1539 companies
in the Chemicals industry
Industry Median: 5.32 vs HKSE:00954: -12.03

Changmao Biochemical Engineering Co Return-on-Tangible-Equity Historical Data

The historical data trend for Changmao Biochemical Engineering Co's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changmao Biochemical Engineering Co Return-on-Tangible-Equity Chart

Changmao Biochemical Engineering Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.76 9.68 12.12 -13.67 -12.79

Changmao Biochemical Engineering Co Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.12 1.15 -27.73 -6.26 -17.48

Competitive Comparison of Changmao Biochemical Engineering Co's Return-on-Tangible-Equity

For the Specialty Chemicals subindustry, Changmao Biochemical Engineering Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Changmao Biochemical Engineering Co's Return-on-Tangible-Equity Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Changmao Biochemical Engineering Co's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Changmao Biochemical Engineering Co's Return-on-Tangible-Equity falls into.


;
;

Changmao Biochemical Engineering Co Return-on-Tangible-Equity Calculation

Changmao Biochemical Engineering Co's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=-72.861/( (612.419+527.336 )/ 2 )
=-72.861/569.8775
=-12.79 %

Changmao Biochemical Engineering Co's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Dec. 2024 )  (Q: Jun. 2024 )(Q: Dec. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Dec. 2024 )  (Q: Jun. 2024 )(Q: Dec. 2024 )
=-105.608/( (680.73+527.336)/ 2 )
=-105.608/604.033
=-17.48 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2024) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Changmao Biochemical Engineering Co  (HKSE:00954) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Changmao Biochemical Engineering Co Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Changmao Biochemical Engineering Co's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Changmao Biochemical Engineering Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1228 Chang Jiang Bei Road, New North Zone, Jiangsu Province, Changzhou City, CHN, 213034
Changmao Biochemical Engineering Co Ltd is an organic acid producer in the PRC. It produces organic acids products for sale to the food additive, chemical, and pharmaceutical industries. Its products are organic acids and their derivatives with four carbons in their structures including fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L(+)-tartaric acid, D(-)-tartaric acid, DL-tartaric acid, L-aspartic acid, and aspartame. These products are used as food additives or medical intermediaries. Its products are produced along vertical production chains. Its geographic locations include Mainland China, Europe includes Great Britain, Germany, Turkey, Spain, and Italy, Asia Pacific includes Hong Kong, Indonesia, Australia, India, Thailand and Japan, America, and Others.
Executives
Leng Yixin 2202 Interest of your spouse
Rui Xinsheng 2101 Beneficial owner

Changmao Biochemical Engineering Co Headlines

No Headlines